When should one stop cholinesterase inhibitors in patients with Alzheimer's disease?
Bogardus
S T
ST
Yale University School of Medicine, New Haven, Connecticut, USA.
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D018450:Disease Progression; D005260:Female; D006801:Humans; D008134:Long-Term Care; D008609:Mental Status Schedule; D016896:Treatment Outcome
D002800:Cholinesterase Inhibitors